Track the 株式会社デ・ウエスタン・セラピテクス研究所 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are listed on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社デ・ウエスタン・セラピテクス研究所 has published 30 insider filings. Market capitalisation: €4.3bn. The latest transaction was disclosed on 27 January 2026 (Holding update). Among the most active insiders: Cantor Fitzgerald Europe. All data is accessible without an account.
30
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,870 of 28,064 companies
32.2
score / 100
Value
14
Quality
50
FCF yld-12%
Earn yld-15%
EV/EBITDA·
ROE-56%
Gross mgn90%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
De Western Therapeutics Institute, Inc. is a Japanese company focused on research and development of innovative therapies in the health and pharmaceutical sector. It aims to create therapeutic solutions for various diseases.